{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:16:53Z","timestamp":1790518613568,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies showed that type 2 short bowel syndrome (SBS) rats were accompanied by severe intestinal bacterial dysbiosis. Limited data are available for intestinal fungal dysbiosis. Moreover, no effective therapeutic drugs are available for these microbiota dysbiosis. The aims of our study were to investigate the therapeutic potential of glucagon-like peptide 2 (GLP-2) for these microbiota dysbiosis in type 2 SBS rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>8-week-old male SD rats which underwent 80% small bowel resection, ileocecum resection, partial colon resection and jejunocolostomy, were treated with saline (SBS group, <jats:italic>n<\/jats:italic>\u00a0=\u20095) or GLP-2 (GLP2.SBS group, <jats:italic>n<\/jats:italic>\u00a0=\u20095). The Sham group rats which underwent transection and re-anastomosis were given a saline placebo (Sham group, <jats:italic>n<\/jats:italic>\u00a0=\u20095). 16S rRNA and ITS sequencing were applied to evaluate the colonic bacterial and fungal composition at 22\u2009days after surgery, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The relative abundance of Actinobacteria, Firmicutes and proinflammatory Proteobacteria increased significantly in SBS group rats, while the relative abundance of Bacteroidetes, Verrucomicrobia and Tenericutes decreased remarkably. GLP-2 treatment significantly decreased Proteus and increased Clostridium relative to the saline treated SBS rats. The diversity of intestinal fungi was significantly increased in SBS rats, accompanied with some fungi abnormally increased and some resident fungi (e.g., Penicillium) significantly decreased. GLP-2 treatment significantly decreased Debaryomyces and Meyerozyma, and increased Penicillium. Moreover, GLP-2 partially restored the bacteria-fungi interkingdom interaction network of SBS rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study confirms the bacterial and fungal dysbiosis in type 2 SBS rats, and GLP-2 partially ameliorated these microbiota dysbiosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06270-w","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:02:43Z","timestamp":1623841363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiuting","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"17","key":"6270_CR1","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.7150\/thno.41802","volume":"10","author":"W Cheng","year":"2020","unstructured":"Cheng W, Wang K, Zhao Z, Mao Q, Wang G, Li Q, et al. Exosomes-mediated transfer of miR-125a\/b in cell-to-cell communication: a novel mechanism of genetic exchange in the intestinal microenvironment. Theranostics. 2020;10(17):7561\u201380. https:\/\/doi.org\/10.7150\/thno.41802.","journal-title":"Theranostics"},{"issue":"2","key":"6270_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10620-019-05802-4","volume":"65","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen A, Guo F, Wang J, Li Y. Severe intestinal Dysbiosis in rat models of short bowel syndrome with Ileocecal resection. Dig Dis Sci. 2020;65(2):431\u201341. https:\/\/doi.org\/10.1007\/s10620-019-05802-4.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"6270_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.sempedsurg.2018.07.007","volume":"27","author":"HG Piper","year":"2018","unstructured":"Piper HG. Intestinal microbiota in short bowel syndrome. Semin Pediatr Surg. 2018;27(4):223\u20138. https:\/\/doi.org\/10.1053\/j.sempedsurg.2018.07.007.","journal-title":"Semin Pediatr Surg"},{"issue":"7","key":"6270_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/0148607116658762","volume":"41","author":"HG Piper","year":"2017","unstructured":"Piper HG, Fan D, Coughlin LA, Ho EX, McDaniel MM, Channabasappa N, et al. Severe gut microbiota Dysbiosis is associated with poor growth in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2017;41(7):1202\u201312. https:\/\/doi.org\/10.1177\/0148607116658762.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"1","key":"6270_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40168-015-0084-7","volume":"3","author":"H Engstrand Lilja","year":"2015","unstructured":"Engstrand Lilja H, Wefer H, Nystr\u00f6m N, Finkel Y, Engstrand L. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome. 2015;3(1):18. https:\/\/doi.org\/10.1186\/s40168-015-0084-7.","journal-title":"Microbiome"},{"issue":"Suppl 1","key":"6270_CR6","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0399-8320(10)70019-1","volume":"34","author":"O Goulet","year":"2010","unstructured":"Goulet O, Joly F. Intestinal microbiota in short bowel syndrome. Gastroenterologie clinique et biologique. 2010;34(Suppl 1):S37\u201343. https:\/\/doi.org\/10.1016\/S0399-8320(10)70019-1.","journal-title":"Gastroenterologie clinique et biologique"},{"issue":"12","key":"6270_CR7","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/jgh.13806","volume":"32","author":"Y Huang","year":"2017","unstructured":"Huang Y, Guo F, Li Y, Wang J, Li J. Fecal microbiota signatures of adult patients with different types of short bowel syndrome. J Gastroenterol Hepatol. 2017;32(12):1949\u201357. https:\/\/doi.org\/10.1111\/jgh.13806.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"6270_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","volume":"69","author":"S Lemoinne","year":"2020","unstructured":"Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C, , Chazouill\u00e8res O, Housset C, Sokol H: Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut 2020, 69:92\u2013102, 1, doi: https:\/\/doi.org\/10.1136\/gutjnl-2018-317791.","journal-title":"Gut"},{"issue":"6","key":"6270_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039\u201348. https:\/\/doi.org\/10.1136\/gutjnl-2015-310746.","journal-title":"Gut"},{"issue":"2","key":"6270_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/19490976.2017.1379637","volume":"9","author":"ML Richard","year":"2018","unstructured":"Richard ML, Liguori G, Lamas B, Brandi G, da Costa G, Hoffmann TW, et al. Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes. 2018;9(2):131\u201342. https:\/\/doi.org\/10.1080\/19490976.2017.1379637.","journal-title":"Gut Microbes"},{"issue":"3","key":"6270_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ibd\/izz207","volume":"26","author":"X Jun","year":"2020","unstructured":"Jun X, Ning C, Yang S, Zhe W, Na W, Yifan Z, et al. Alteration of fungal microbiota after 5-ASA treatment in UC patients. Inflamm Bowel Dis. 2020;26(3):380\u201390. https:\/\/doi.org\/10.1093\/ibd\/izz207.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"6270_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41574-019-0168-8","volume":"15","author":"FM Gribble","year":"2019","unstructured":"Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol. 2019;15(4):226\u201337. https:\/\/doi.org\/10.1038\/s41574-019-0168-8.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"6270_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.14336\/AD.2017.1001","volume":"9","author":"J Wu","year":"2018","unstructured":"Wu J, Ren W, Li L, Luo M, Xu K, Shen J, et al. Effect of aging and glucagon-like peptide 2 on intestinal microbiota in SD rats. Aging Dis. 2018;9(4):566\u201377. https:\/\/doi.org\/10.14336\/AD.2017.1001.","journal-title":"Aging Dis"},{"issue":"21","key":"6270_CR14","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Mago\u010d","year":"2011","unstructured":"Mago\u010d T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics (Oxford, England). 2011;27(21):2957\u201363.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"10","key":"6270_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996\u20138. https:\/\/doi.org\/10.1038\/nmeth.2604.","journal-title":"Nat Methods"},{"issue":"16","key":"6270_CR16","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics (Oxford, England). 2011;27(16):2194\u2013200.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"5","key":"6270_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335\u20136. https:\/\/doi.org\/10.1038\/nmeth.f.303.","journal-title":"Nat Methods"},{"issue":"6","key":"6270_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41575-019-0121-2","volume":"16","author":"ML Richard","year":"2019","unstructured":"Richard ML, Sokol H. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2019;16(6):331\u201345. https:\/\/doi.org\/10.1038\/s41575-019-0121-2.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"6270_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.30832","volume":"71","author":"S Lang","year":"2020","unstructured":"Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, et al. Intestinal fungal Dysbiosis and systemic immune response to Fungi in patients with alcoholic hepatitis. Hepatology. 2020;71(2):522\u201338. https:\/\/doi.org\/10.1002\/hep.30832.","journal-title":"Hepatology"},{"key":"6270_CR20","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3389\/fmicb.2018.03249","volume":"9","author":"JD Forbes","year":"2018","unstructured":"Forbes JD, Bernstein CN, Tremlett H, Van Domselaar G, Knox NC. A fungal world: could the gut Mycobiome be involved in neurological disease? Front Microbiol. 2018;9:3249.","journal-title":"Front Microbiol"},{"issue":"6","key":"6270_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.chom.2017.10.013","volume":"22","author":"TT Jiang","year":"2017","unstructured":"Jiang TT, Shao TY, Ang WXG, Kinder JM, Turner LH, Pham G, et al. Commensal fungi recapitulate the protective benefits of intestinal bacteria. Cell Host Microbe. 2017;22(6):809\u2013816.e804.","journal-title":"Cell Host Microbe"},{"key":"6270_CR22","doi-asserted-by":"publisher","first-page":"9560684","DOI":"10.1155\/2020\/9560684","volume":"2020","author":"VK Chin","year":"2020","unstructured":"Chin VK, Yong VC, Chong PP, Amin Nordin S, Basir R, Abdullah M. Mycobiome in the gut: a multiperspective review. Mediat Inflamm. 2020;2020:9560684.","journal-title":"Mediat Inflamm"},{"issue":"3","key":"6270_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4161\/gmic.24372","volume":"4","author":"S Lapthorne","year":"2013","unstructured":"Lapthorne S, Pereira-Fantini PM, Fouhy F, Wilson G, Thomas SL, Dellios NL, et al. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome. Gut Microbes. 2013;4(3):212\u201321. https:\/\/doi.org\/10.4161\/gmic.24372.","journal-title":"Gut Microbes"},{"issue":"6","key":"6270_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0148607115626903","volume":"41","author":"CL Levesque","year":"2017","unstructured":"Levesque CL, Turner J, Li J, Wizzard P, St Pierre B, Lim D, et al. In a neonatal piglet model of intestinal failure, Administration of Antibiotics and Lack of enteral nutrition have a greater impact on intestinal microflora than surgical resection alone. JPEN J Parenter Enteral Nutr. 2017;41(6):938\u201345. https:\/\/doi.org\/10.1177\/0148607115626903.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"8","key":"6270_CR25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0148607115591216","volume":"40","author":"ZH Davidovics","year":"2016","unstructured":"Davidovics ZH, Carter BA, Luna RA, Hollister EB, Shulman RJ, Versalovic J. The fecal microbiome in pediatric patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2016;40(8):1106\u201313. https:\/\/doi.org\/10.1177\/0148607115591216.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"6270_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jamcollsurg.2018.07.657","volume":"227","author":"HJ Engelstad","year":"2018","unstructured":"Engelstad HJ, Barron L, Moen J, Wylie TN, Wylie K, Rubin DC, et al. Remnant small bowel length in pediatric short bowel syndrome and the correlation with intestinal Dysbiosis and linear growth. J Am Coll Surg. 2018;227(4):439\u201349. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2018.07.657.","journal-title":"J Am Coll Surg"},{"issue":"9","key":"6270_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496\u2013503. https:\/\/doi.org\/10.1016\/j.tibtech.2015.06.011.","journal-title":"Trends Biotechnol"},{"issue":"6","key":"6270_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1194\/jlr.R067629","volume":"57","author":"P Sch\u00f6nfeld","year":"2016","unstructured":"Sch\u00f6nfeld P, Wojtczak L. Short- and medium-chain fatty acids in energy metabolism: the cellular perspective. J Lipid Res. 2016;57(6):943\u201354. https:\/\/doi.org\/10.1194\/jlr.R067629.","journal-title":"J Lipid Res"},{"issue":"7","key":"6270_CR29","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s10620-018-5428-2","volume":"64","author":"Y Qing","year":"2019","unstructured":"Qing Y, Xie H, Su C, Wang Y, Yu Q, Pang Q, et al. Gut microbiome, short-chain fatty acids, and mucosa injury in young adults with human immunodeficiency virus infection. Dig Dis Sci. 2019;64(7):1830\u201343. https:\/\/doi.org\/10.1007\/s10620-018-5428-2.","journal-title":"Dig Dis Sci"},{"key":"6270_CR30","doi-asserted-by":"publisher","first-page":"591408","DOI":"10.3389\/fcell.2020.591408","volume":"8","author":"Y Ma","year":"2020","unstructured":"Ma Y, Hu C, Yan W, Jiang H, Liu G. Lactobacillus pentosus increases the abundance of Akkermansia and affects the serum Metabolome to alleviate DSS-induced colitis in a murine model. Front Cell Dev Biol. 2020;8:591408. https:\/\/doi.org\/10.3389\/fcell.2020.591408.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"6270_CR31","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","volume":"69","author":"L Wang","year":"2020","unstructured":"Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+)T cells in mice. Gut. 2020;69(11):1988\u201397. https:\/\/doi.org\/10.1136\/gutjnl-2019-320105.","journal-title":"Gut"},{"issue":"7","key":"6270_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103. https:\/\/doi.org\/10.1038\/s41591-019-0495-2.","journal-title":"Nat Med"},{"key":"6270_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fmicb.2020.00219","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu Y, Wang N, Tan HY, Li S, Zhang C, Feng Y. Function of Akkermansia muciniphila in obesity: interactions with lipid metabolism, immune response and gut systems. Front Microbiol. 2020;11:219.","journal-title":"Front Microbiol"},{"issue":"9","key":"6270_CR34","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79. https:\/\/doi.org\/10.1186\/gb-2012-13-9-r79.","journal-title":"Genome Biol"},{"issue":"4","key":"6270_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/jpen.1701","volume":"44","author":"AC Fifi","year":"2020","unstructured":"Fifi AC, Bayes L, Ehrenpreis ED, Chavez H. Prevalence of bloodstream infections in children with short-bowel syndrome with a central line presenting to emergency department with fever. JPEN J Parenter Enteral Nutr. 2020;44(4):655\u201360. https:\/\/doi.org\/10.1002\/jpen.1701.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"1","key":"6270_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MPG.0000000000002506","volume":"70","author":"BP Raphael","year":"2020","unstructured":"Raphael BP, Fournier G, McLaughlin SR, Puder M, Jones S, Flett KB. Antibiotic susceptibility and therapy in central line infections in pediatric home parenteral nutrition patients. J Pediatr Gastroenterol Nutr. 2020;70(1):59\u201363. https:\/\/doi.org\/10.1097\/MPG.0000000000002506.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"6270_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/ecco-jcc\/jjw197","volume":"11","author":"M El Mouzan","year":"2017","unstructured":"El Mouzan M, Wang F, Al Mofarreh M, Menon R, Al Barrag A, Korolev KS, et al. Fungal microbiota profile in newly diagnosed treatment-na\u00efve children with Crohn's disease. J Crohn\u2019s Colitis. 2017;11(5):586\u201392. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw197.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"6270_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12864-015-2347-x","volume":"17","author":"H Banani","year":"2016","unstructured":"Banani H, Marcet-Houben M, Ballester AR, Abbruscato P, Gonz\u00e1lez-Candelas L, Gabald\u00f3n T, et al. Genome sequencing and secondary metabolism of the postharvest pathogen Penicillium griseofulvum. BMC Genomics. 2016;17(1):19. https:\/\/doi.org\/10.1186\/s12864-015-2347-x.","journal-title":"BMC Genomics"},{"issue":"5","key":"6270_CR39","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrmicro2313","volume":"8","author":"AY Peleg","year":"2010","unstructured":"Peleg AY, Hogan DA, Mylonakis E. Medically important bacterial-fungal interactions. Nat Rev Microbiol. 2010;8(5):340\u20139. https:\/\/doi.org\/10.1038\/nrmicro2313.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"6270_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00535-018-1530-7","volume":"54","author":"T Imai","year":"2019","unstructured":"Imai T, Inoue R, Kawada Y, Morita Y, Inatomi O, Nishida A, et al. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2019;54(2):149\u201359. https:\/\/doi.org\/10.1007\/s00535-018-1530-7.","journal-title":"J Gastroenterol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06270-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06270-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06270-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:03:46Z","timestamp":1623841426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06270-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6270"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06270-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocols were approved by the Institutional Ethics Committee of Life Sciences School of Nanjing University and performed according to guideline for the care and use of laboratory animals published by the National Institutes of Health (8 Edition). And all methods were carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"583"}}